Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?

Purpose of review A number of molecular characteristics are essential for accurate diagnosis and prognostication in glioma. Recent findings The 2021 WHO classification of brain tumors and recent Food and Drug Administration (FDA) pathology agnostic drug approvals highlight the importance of molecula...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current oncology reports 2024-11, Vol.26 (11), p.1277-1282
1. Verfasser:	Alnahhas, Iyad
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers, Tumor - genetics Brain cancer Brain Neoplasms - diagnosis Brain Neoplasms - drug therapy Brain Neoplasms - genetics Brain tumors Cancer therapies Cell cycle Chemotherapy Chromosomes Classification Clinical medicine Clinical trials DNA Methylation DNA Modification Methylases - genetics DNA Repair Enzymes - genetics FDA approval Glioblastoma Glioma Glioma - drug therapy Glioma - genetics Growth factors Humans Isocitrate Dehydrogenase - genetics Kinases Medical prognosis Medicine Medicine & Public Health Mutation Nervous system Oncology Prognosis Radiation therapy Review Temozolomide Topical Collection on Neuro-oncology Tumor Suppressor Proteins - genetics Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!